VA's Pharmacy Prime Vendor Contract for FY2017 Q3 Awarded to McKesson Corporation for $47.5M
Contract Overview
Contract Amount: $47,477,713 ($47.5M)
Contractor: Mckesson Corporation
Awarding Agency: Department of Veterans Affairs
Start Date: 2017-06-01
End Date: 2017-08-31
Contract Duration: 91 days
Daily Burn Rate: $521.7K/day
Competition Type: FULL AND OPEN COMPETITION
Number of Offers Received: 5
Pricing Type: FIRM FIXED PRICE
Sector: Healthcare
Official Description: EXPRESS REPORT: PHARMACY PRIME VENDOR (PPV) FY2017 JUN-AUG
Place of Performance
Location: DULUTH, GWINNETT County, GEORGIA, 30096
State: Georgia Government Spending
Plain-Language Summary
Department of Veterans Affairs obligated $47.5 million to MCKESSON CORPORATION for work described as: EXPRESS REPORT: PHARMACY PRIME VENDOR (PPV) FY2017 JUN-AUG Key points: 1. The Department of Veterans Affairs awarded a significant contract for pharmaceutical supplies. 2. McKesson Corporation, a major player in the pharmaceutical distribution market, secured the award. 3. The contract was awarded under full and open competition, suggesting a competitive bidding process. 4. The spending period covers three months in FY2017, indicating a recurring need for these services.
Value Assessment
Rating: good
The contract's value of $47.5M over three months suggests a substantial volume of pharmaceutical purchases. Benchmarking against similar large-scale pharmaceutical distribution contracts would be necessary for a precise value assessment, but the firm fixed price indicates cost certainty for the VA.
Cost Per Unit: N/A
Competition Analysis
Competition Level: full-and-open
The contract was awarded through full and open competition, which typically fosters competitive pricing and allows for a broad range of potential bidders. This method is expected to yield fair market prices for the pharmaceutical supplies.
Taxpayer Impact: The competitive nature of this award is beneficial for taxpayers, as it aims to secure the best possible price for essential pharmaceutical products for veterans.
Public Impact
Ensures timely access to essential medications for veterans. Supports the operational needs of VA healthcare facilities nationwide. Contributes to the stability of the pharmaceutical supply chain for a critical government agency.
Waste & Efficiency Indicators
Waste Risk Score: 50 / 10
Warning Flags
- Potential for price fluctuations in pharmaceutical markets.
- Dependence on a single vendor for a critical supply chain.
Positive Signals
- Awarded via full and open competition.
- Firm fixed price contract provides cost predictability.
- Supports a vital government function (veteran healthcare).
Sector Analysis
This contract falls within the pharmaceutical preparation manufacturing and distribution sector. Spending in this area is crucial for public health and national security, with significant government contracts awarded to major distributors like McKesson.
Small Business Impact
While the prime vendor is a large corporation, the contract's nature as a large-scale distribution agreement may limit direct subcontracting opportunities for small businesses in the pharmaceutical manufacturing itself. However, ancillary services related to logistics and delivery could potentially involve small businesses.
Oversight & Accountability
The Department of Veterans Affairs is responsible for overseeing this contract. Regular performance reviews and audits would be standard to ensure compliance with terms and conditions, and to monitor delivery and quality of pharmaceuticals.
Related Government Programs
- Pharmaceutical Preparation Manufacturing
- Department of Veterans Affairs Contracting
- Department of Veterans Affairs Programs
Risk Flags
- Supply chain disruption risk.
- Potential for price increases in future contract periods.
- Dependence on a single large supplier.
- Regulatory compliance risks in pharmaceutical handling.
Tags
pharmaceutical-preparation-manufacturing, department-of-veterans-affairs, ga, delivery-order, 10m-plus
Frequently Asked Questions
What is this federal contract paying for?
Department of Veterans Affairs awarded $47.5 million to MCKESSON CORPORATION. EXPRESS REPORT: PHARMACY PRIME VENDOR (PPV) FY2017 JUN-AUG
Who is the contractor on this award?
The obligated recipient is MCKESSON CORPORATION.
Which agency awarded this contract?
Awarding agency: Department of Veterans Affairs (Department of Veterans Affairs).
What is the total obligated amount?
The obligated amount is $47.5 million.
What is the period of performance?
Start: 2017-06-01. End: 2017-08-31.
What is the historical spending trend for the Pharmacy Prime Vendor contract?
Analyzing historical spending data for the Pharmacy Prime Vendor contract is crucial to understand if the current award of $47.5M for FY2017 Q3 represents an increase, decrease, or stable expenditure compared to previous periods. This trend analysis helps identify potential cost efficiencies or escalating costs over time and informs future budget projections.
What are the key performance indicators (KPIs) used to evaluate McKesson Corporation's performance under this contract?
Key performance indicators for this contract likely include on-time delivery rates, order accuracy, drug availability, and adherence to temperature control and handling standards for pharmaceuticals. The VA would monitor these KPIs to ensure the reliability and quality of the supply chain, mitigating risks associated with medication shortages or spoilage.
How does the VA ensure the quality and efficacy of pharmaceuticals procured through this prime vendor contract?
The VA ensures pharmaceutical quality and efficacy through stringent vendor qualification processes, adherence to FDA regulations, and potentially through its own internal quality assurance checks. The contract likely includes specifications for product sourcing, handling, and storage, with provisions for addressing any deviations or quality issues that may arise.
Industry Classification
NAICS: Manufacturing › Pharmaceutical and Medicine Manufacturing › Pharmaceutical Preparation Manufacturing
Product/Service Code: MEDICAL/DENTAL/VETERINARY EQPT/SUPP
Competition & Pricing
Extent Competed: FULL AND OPEN COMPETITION
Solicitation Procedures: NEGOTIATED PROPOSAL/QUOTE
Offers Received: 5
Pricing Type: FIRM FIXED PRICE (J)
Evaluated Preference: NONE
Contractor Details
Address: ONE POST ST, SAN FRANCISCO, CA, 94104
Business Categories: Category Business, Corporate Entity Not Tax Exempt, Not Designated a Small Business, Special Designations, U.S.-Owned Business
Financial Breakdown
Contract Ceiling: $47,477,713
Exercised Options: $47,477,713
Current Obligation: $47,477,713
Contract Characteristics
Commercial Item: COMMERCIAL ITEM
Cost or Pricing Data: NO
Parent Contract
Parent Award PIID: VA797P12D0001
IDV Type: IDC
Timeline
Start Date: 2017-06-01
Current End Date: 2017-08-31
Potential End Date: 2017-08-31 00:00:00
Last Modified: 2019-08-20
More Contracts from Mckesson Corporation
- Express Report: Pharmaceutical Prime Vendor (ppv)fy2026 November — $1.4B (Department of Veterans Affairs)
- Express Report: Pharmaceutical Prime Vendor (ppv)fy2026 October — $1.2B (Department of Veterans Affairs)
- Express Report: Pharmaceutical Prime Vendor (ppv)fy2025 September — $1.2B (Department of Veterans Affairs)
- Express Report: Pharmaceutical Prime Vendor (ppv)fy2025 July — $1.1B (Department of Veterans Affairs)
- Express Report: Pharmaceutical Prime Vendor (ppv)fy2026 December — $1.1B (Department of Veterans Affairs)
Other Department of Veterans Affairs Contracts
- CCN Region 3 Express Report — $5.2B (Optum Public Sector Solutions, Inc.)
- Express Report for FY22 Region 2 — $5.1B (Optum Public Sector Solutions, Inc.)
- Fiscal Year 2022 Express Report for Region 1 — $4.2B (Optum Public Sector Solutions, Inc.)
- Express Report for the Patient Centered Community Care (PC3) Contract — $3.3B (Triwest Healthcare Alliance Corp)
- CCN Region Three FY21 Express Report — $3.1B (Optum Public Sector Solutions, Inc.)